封面
市场调查报告书
商品编码
1862160

横向流动化验检测:全球市场份额和排名、总收入和需求预测(2025-2031 年)

Lateral Flow Assay Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

出版日期: | 出版商: QYResearch | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球横向流动化验侦测市场预计在 2024 年达到 58.92 亿美元,预计到 2031 年将达到 85.66 亿美元,2025 年至 2031 年的复合年增长率为 6.2%。

横向流动化验是一种简单的诊断设备,用于确认人类和动物体内是否有感兴趣的分析物,例如病原体和生物标记物,或自来水、食物和饲料中的污染物。

全球横向流动化验检测市场的主要企业包括赛默飞世尔科技(Thermo Fisher)和贝克顿·迪金森公司(Becton Dickinson)。这两家公司合计占约25%的总合。北美是最大的市场,市占率超过35%,其次是欧洲和亚太地区,市占率均约为55%。依产品类型划分,夹心法检测是最大的细分市场,约占市场占有率的65%。按应用领域划分,医疗领域是最大的应用领域,其次是环境检测和食品安全。

侧向流动检测产业:技术主导的市场创新与公司转型

在技​​术创新的驱动下,侧向流动检测产业正在重塑医疗诊断、食品安全和环境监测等领域的检测模式。其核心优势在于操作简单、快速定性分析,应用范围从病原体检测扩展到污染物筛检,应用场景也日益多元化。目前,该产业的技术演进正从传统检测套组转向数位化、智慧型设备。数位化和行动读板的广泛应用显着提高了检测效率和数据可追溯性,而优化检测套组的灵敏度和特异性已成为竞争优势。这项技术演进不仅满足了医疗领域对即时就地检验(POC​​T)的需求,也有助于食品加工企业提升原料污染快速筛检能力,进而形成「技术-应用-需求」的良性循环。

市场动态与成长逻辑:需求扩张与政策的综效

不断增长的市场需求是推动产业成长的核心动力。在医疗健康领域,从三级医疗机构到基层医疗机构,对携带式检测设备的需求激增,带动试剂和设备市场的同步扩张。在食品业,在「从农场到餐桌」的全面监管体系下,企业对快速检测技术的投资稳定成长。在政策层面,政府透过《支持新型产业生产力发展的计量行动计画(2025-2030年)》等文件,将计量技术纳入策略支援领域,鼓励企业克服技术瓶颈。同时,资本市场对该产业的兴趣也显着提升。根据主要证券机构的研究报告显示,在有利的政策和流动性支持下,到2025年,侧向流动检测行业的业绩和估值预计将呈指数级增长。尤其具有国际竞争力的企业,正透过跨国併购和海外扩张不断扩大全球市场份额。商业展望:技术壁垒、深化发展情境与生态系统建设

主要企业正透过三大途径强化自身竞争优势。首先,它们建构技术壁垒。例如,丹纳赫和Bio-Rad透过持续的研发投入,在试剂灵敏度和仪器整合方面建构了专利支援的防御体系。其次,基于场景的解决方案正从独立产品转向「检测+资讯服务」。例如,它们为医院提供客製化的检测方案,并为食品企业建立全流程可追溯性系统。第三,全球生态系统协作正在促进合作。主要企业正透过併购和设立海外分公司拓展国际市场。例如,中金公司正利用其国际影响力,透过在香港进行股权资金筹措快速扩张;而中国银河证券则透过其东南亚子公司扩大其在证券经纪市场的份额。此外,区块链和物联网等技术的融合正在建立封闭回路型生态系统。例如,将检测数据与区块链结合,可以确保食品供应链的透明度和可追溯性。

展望:创新重塑产业格局

侧向流动检测产业的未来属于那些能够将技术突破转化为增值应用场景的企业。人工智慧、巨量资料与环境等关键领域。同时,透过全球扩张和生态系统合作,企业可以从「检测工具提供者」转型为「产业解决方案领导者」。在此过程中,那些展现出持续创新能力并精准掌握客户需求的企业,将在技术主导的产业转型中占据主导。

本报告旨在按地区/国家、类型和应用对全球横向流动化验检测市场进行全面分析,重点关注总收入、市场份额和主要企业的排名。

本报告以销售收入为指标,对横向流动化验市场规模、估算和预测进行了呈现,以 2024 年为基准年,并包含了 2020 年至 2031 年的历史数据和预测数据。透过定量和定性分析,我们帮助读者制定业务/成长策略,评估竞争格局,分析自身在当前市场中的地位,并就横向流动化验做出明智的商业决策。

市场区隔

公司

  • Thermo Fisher
  • Becton Dickinson
  • Abbott
  • Hologic, Inc.
  • PerkinElmer
  • Quidel Corporation
  • Biomerieux
  • Cytiva(Danaher)
  • Qiagen
  • Siemens
  • BUHLMANN
  • IMMY

按类型分類的细分市场

  • 夹心法
  • 竞争性检测

应用领域

  • 製药
  • 环境测试
  • 食品安全

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Lateral Flow Assay Test was estimated to be worth US$ 5892 million in 2024 and is forecast to a readjusted size of US$ 8566 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.

Global Lateral Flow Assay Test key players include Thermo Fisher, Becton Dickinson, etc. Global top two manufacturers hold a share nearly 25%. North America is the largest market, with a share over 35%, followed by Europe, Asia-Pacific, both have a share about 55 percent. In terms of product, Sandwich Assays is the largest segment, with a share about 65%. And in terms of application, the largest application is Medicine, followed by Environment Testing, Food Safety, etc.

Lateral Flow Test Industry: Technology-Driven Market Innovation and Enterprise Transformation

The lateral flow test industry, driven by technological iteration, is reshaping the testing paradigm in fields such as medical diagnostics, food safety, and environmental monitoring. Its essence lies in enabling rapid qualitative analysis through simple operation, extending its reach from pathogen detection to contaminant screening, and its application scenarios continue to diversify. Currently, the industry's technological path is shifting from traditional test kits to digital and intelligent devices. The widespread adoption of digital/mobile readers has significantly improved testing efficiency and data traceability, while optimizing test kit sensitivity and specificity has become a key differentiator in competitive competition. This technological evolution not only meets the medical field's demand for immediate point-of-care testing (POCT) but also drives food processing companies to upgrade their capabilities for rapid screening of raw material contamination, creating a virtuous cycle of "technology-application-demand."

Market Dynamics and Growth Logic: Increasing Demand and Policy Resonance

Increasing market demand has become the core driver of industry growth. In the medical sector, from tertiary hospitals to primary care clinics, demand for portable testing equipment has surged, driving the simultaneous expansion of the reagent and instrument markets. In the food industry, under comprehensive "farm-to-table" oversight, companies' investment in rapid testing technology has steadily increased. On the policy front, the government, through documents such as the "Action Plan for Metrology to Support the Development of New Industrial Productivity (2025-2030)," has incorporated metrology technology into strategic support areas, encouraging companies to overcome key technological bottlenecks. Meanwhile, capital markets are significantly increasing their interest in the industry. Research reports from leading brokerages indicate that the lateral flow testing sector is expected to see a boost in both performance and valuation by 2025, driven by favorable policies and liquidity. Internationally competitive companies, in particular, are seizing global market share through cross-border mergers and acquisitions and overseas expansion. Business Outlook: Technological Barriers, Deepening Scenario Development, and Ecosystem Building

Leading companies are consolidating their competitive advantages through three main approaches: First, building technological barriers. For example, Danaher and Bio-Rad have built patent moats in reagent sensitivity and device integration through continuous R&D investment. Second, scenario-based solutions are transitioning from single products to "testing + data services." For example, they offer customized testing packages to hospitals or build full-process traceability systems for food companies. Third, global ecosystem collaboration is fostering collaboration. Leading companies are expanding into international markets through mergers and acquisitions or establishing overseas branches. For example, CICC, leveraging its international presence, has rapidly expanded in Hong Kong equity financing, while China Galaxy Securities is increasing its brokerage market share through its Southeast Asian subsidiary. Furthermore, the integration of technologies like blockchain and the Internet of Things is fostering a closed-loop ecosystem of "testing-data-decision-making." For example, combining test data with blockchain ensures transparency and traceability in the food supply chain.

Future Outlook: Industry Restructuring Driven by Innovation

The future of the lateral flow testing industry belongs to those companies that can transform technological breakthroughs into valuable scenarios. With the deep integration of artificial intelligence, big data, and testing technologies, intelligent testing platforms will become standard, and policy support and capital injection will accelerate industry restructuring. Companies need to leverage "technology + scenarios + ecosystem" as their strategic fulcrum, delving deeply into essential sectors like healthcare, food, and the environment. Simultaneously, through global expansion and ecosystem collaboration, they can upgrade from "testing tool providers" to "industry solution leaders." In this process, those who consistently innovate and accurately understand customer needs will seize the initiative in this technology-driven industrial transformation.

This report aims to provide a comprehensive presentation of the global market for Lateral Flow Assay Test, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Lateral Flow Assay Test by region & country, by Type, and by Application.

The Lateral Flow Assay Test market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lateral Flow Assay Test.

Market Segmentation

By Company

  • Thermo Fisher
  • Becton Dickinson
  • Abbott
  • Hologic, Inc.
  • PerkinElmer
  • Quidel Corporation
  • Biomerieux
  • Cytiva (Danaher)
  • Qiagen
  • Siemens
  • BUHLMANN
  • IMMY

Segment by Type

  • Sandwich Assays
  • Competitive Assays

Segment by Application

  • Medicine
  • Environment Testing
  • Food Safety

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Lateral Flow Assay Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Lateral Flow Assay Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Lateral Flow Assay Test in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Lateral Flow Assay Test Product Introduction
  • 1.2 Global Lateral Flow Assay Test Market Size Forecast (2020-2031)
  • 1.3 Lateral Flow Assay Test Market Trends & Drivers
    • 1.3.1 Lateral Flow Assay Test Industry Trends
    • 1.3.2 Lateral Flow Assay Test Market Drivers & Opportunity
    • 1.3.3 Lateral Flow Assay Test Market Challenges
    • 1.3.4 Lateral Flow Assay Test Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Lateral Flow Assay Test Players Revenue Ranking (2024)
  • 2.2 Global Lateral Flow Assay Test Revenue by Company (2020-2025)
  • 2.3 Key Companies Lateral Flow Assay Test Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Lateral Flow Assay Test Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Lateral Flow Assay Test
  • 2.6 Lateral Flow Assay Test Market Competitive Analysis
    • 2.6.1 Lateral Flow Assay Test Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Lateral Flow Assay Test Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lateral Flow Assay Test as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Sandwich Assays
    • 3.1.2 Competitive Assays
  • 3.2 Global Lateral Flow Assay Test Sales Value by Type
    • 3.2.1 Global Lateral Flow Assay Test Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Lateral Flow Assay Test Sales Value, by Type (2020-2031)
    • 3.2.3 Global Lateral Flow Assay Test Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Medicine
    • 4.1.2 Environment Testing
    • 4.1.3 Food Safety
  • 4.2 Global Lateral Flow Assay Test Sales Value by Application
    • 4.2.1 Global Lateral Flow Assay Test Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Lateral Flow Assay Test Sales Value, by Application (2020-2031)
    • 4.2.3 Global Lateral Flow Assay Test Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Lateral Flow Assay Test Sales Value by Region
    • 5.1.1 Global Lateral Flow Assay Test Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Lateral Flow Assay Test Sales Value by Region (2020-2025)
    • 5.1.3 Global Lateral Flow Assay Test Sales Value by Region (2026-2031)
    • 5.1.4 Global Lateral Flow Assay Test Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Lateral Flow Assay Test Sales Value, 2020-2031
    • 5.2.2 North America Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Lateral Flow Assay Test Sales Value, 2020-2031
    • 5.3.2 Europe Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Lateral Flow Assay Test Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Lateral Flow Assay Test Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Lateral Flow Assay Test Sales Value, 2020-2031
    • 5.5.2 South America Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Lateral Flow Assay Test Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Lateral Flow Assay Test Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Lateral Flow Assay Test Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.3.2 United States Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.4.2 Europe Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.5.2 China Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.6.2 Japan Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.7.2 South Korea Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Lateral Flow Assay Test Sales Value, 2020-2031
    • 6.9.2 India Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Lateral Flow Assay Test Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Thermo Fisher
    • 7.1.1 Thermo Fisher Profile
    • 7.1.2 Thermo Fisher Main Business
    • 7.1.3 Thermo Fisher Lateral Flow Assay Test Products, Services and Solutions
    • 7.1.4 Thermo Fisher Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Thermo Fisher Recent Developments
  • 7.2 Becton Dickinson
    • 7.2.1 Becton Dickinson Profile
    • 7.2.2 Becton Dickinson Main Business
    • 7.2.3 Becton Dickinson Lateral Flow Assay Test Products, Services and Solutions
    • 7.2.4 Becton Dickinson Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Becton Dickinson Recent Developments
  • 7.3 Abbott
    • 7.3.1 Abbott Profile
    • 7.3.2 Abbott Main Business
    • 7.3.3 Abbott Lateral Flow Assay Test Products, Services and Solutions
    • 7.3.4 Abbott Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Abbott Recent Developments
  • 7.4 Hologic, Inc.
    • 7.4.1 Hologic, Inc. Profile
    • 7.4.2 Hologic, Inc. Main Business
    • 7.4.3 Hologic, Inc. Lateral Flow Assay Test Products, Services and Solutions
    • 7.4.4 Hologic, Inc. Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Hologic, Inc. Recent Developments
  • 7.5 PerkinElmer
    • 7.5.1 PerkinElmer Profile
    • 7.5.2 PerkinElmer Main Business
    • 7.5.3 PerkinElmer Lateral Flow Assay Test Products, Services and Solutions
    • 7.5.4 PerkinElmer Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.5.5 PerkinElmer Recent Developments
  • 7.6 Quidel Corporation
    • 7.6.1 Quidel Corporation Profile
    • 7.6.2 Quidel Corporation Main Business
    • 7.6.3 Quidel Corporation Lateral Flow Assay Test Products, Services and Solutions
    • 7.6.4 Quidel Corporation Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Quidel Corporation Recent Developments
  • 7.7 Biomerieux
    • 7.7.1 Biomerieux Profile
    • 7.7.2 Biomerieux Main Business
    • 7.7.3 Biomerieux Lateral Flow Assay Test Products, Services and Solutions
    • 7.7.4 Biomerieux Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Biomerieux Recent Developments
  • 7.8 Cytiva (Danaher)
    • 7.8.1 Cytiva (Danaher) Profile
    • 7.8.2 Cytiva (Danaher) Main Business
    • 7.8.3 Cytiva (Danaher) Lateral Flow Assay Test Products, Services and Solutions
    • 7.8.4 Cytiva (Danaher) Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Cytiva (Danaher) Recent Developments
  • 7.9 Qiagen
    • 7.9.1 Qiagen Profile
    • 7.9.2 Qiagen Main Business
    • 7.9.3 Qiagen Lateral Flow Assay Test Products, Services and Solutions
    • 7.9.4 Qiagen Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Qiagen Recent Developments
  • 7.10 Siemens
    • 7.10.1 Siemens Profile
    • 7.10.2 Siemens Main Business
    • 7.10.3 Siemens Lateral Flow Assay Test Products, Services and Solutions
    • 7.10.4 Siemens Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Siemens Recent Developments
  • 7.11 BUHLMANN
    • 7.11.1 BUHLMANN Profile
    • 7.11.2 BUHLMANN Main Business
    • 7.11.3 BUHLMANN Lateral Flow Assay Test Products, Services and Solutions
    • 7.11.4 BUHLMANN Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.11.5 BUHLMANN Recent Developments
  • 7.12 IMMY
    • 7.12.1 IMMY Profile
    • 7.12.2 IMMY Main Business
    • 7.12.3 IMMY Lateral Flow Assay Test Products, Services and Solutions
    • 7.12.4 IMMY Lateral Flow Assay Test Revenue (US$ Million) & (2020-2025)
    • 7.12.5 IMMY Recent Developments

8 Industry Chain Analysis

  • 8.1 Lateral Flow Assay Test Industrial Chain
  • 8.2 Lateral Flow Assay Test Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Lateral Flow Assay Test Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Lateral Flow Assay Test Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Lateral Flow Assay Test Market Trends
  • Table 2. Lateral Flow Assay Test Market Drivers & Opportunity
  • Table 3. Lateral Flow Assay Test Market Challenges
  • Table 4. Lateral Flow Assay Test Market Restraints
  • Table 5. Global Lateral Flow Assay Test Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Lateral Flow Assay Test Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Lateral Flow Assay Test Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Lateral Flow Assay Test Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Lateral Flow Assay Test
  • Table 10. Global Lateral Flow Assay Test Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lateral Flow Assay Test as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Lateral Flow Assay Test Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Lateral Flow Assay Test Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Lateral Flow Assay Test Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Lateral Flow Assay Test Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Lateral Flow Assay Test Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Lateral Flow Assay Test Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Lateral Flow Assay Test Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Lateral Flow Assay Test Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Lateral Flow Assay Test Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Lateral Flow Assay Test Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Lateral Flow Assay Test Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Lateral Flow Assay Test Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Lateral Flow Assay Test Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Lateral Flow Assay Test Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Lateral Flow Assay Test Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Lateral Flow Assay Test Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Lateral Flow Assay Test Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Lateral Flow Assay Test Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Thermo Fisher Basic Information List
  • Table 32. Thermo Fisher Description and Business Overview
  • Table 33. Thermo Fisher Lateral Flow Assay Test Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Lateral Flow Assay Test Business of Thermo Fisher (2020-2025)
  • Table 35. Thermo Fisher Recent Developments
  • Table 36. Becton Dickinson Basic Information List
  • Table 37. Becton Dickinson Description and Business Overview
  • Table 38. Becton Dickinson Lateral Flow Assay Test Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Lateral Flow Assay Test Business of Becton Dickinson (2020-2025)
  • Table 40. Becton Dickinson Recent Developments
  • Table 41. Abbott Basic Information List
  • Table 42. Abbott Description and Business Overview
  • Table 43. Abbott Lateral Flow Assay Test Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Lateral Flow Assay Test Business of Abbott (2020-2025)
  • Table 45. Abbott Recent Developments
  • Table 46. Hologic, Inc. Basic Information List
  • Table 47. Hologic, Inc. Description and Business Overview
  • Table 48. Hologic, Inc. Lateral Flow Assay Test Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Lateral Flow Assay Test Business of Hologic, Inc. (2020-2025)
  • Table 50. Hologic, Inc. Recent Developments
  • Table 51. PerkinElmer Basic Information List
  • Table 52. PerkinElmer Description and Business Overview
  • Table 53. PerkinElmer Lateral Flow Assay Test Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Lateral Flow Assay Test Business of PerkinElmer (2020-2025)
  • Table 55. PerkinElmer Recent Developments
  • Table 56. Quidel Corporation Basic Information List
  • Table 57. Quidel Corporation Description and Business Overview
  • Table 58. Quidel Corporation Lateral Flow Assay Test Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Lateral Flow Assay Test Business of Quidel Corporation (2020-2025)
  • Table 60. Quidel Corporation Recent Developments
  • Table 61. Biomerieux Basic Information List
  • Table 62. Biomerieux Description and Business Overview
  • Table 63. Biomerieux Lateral Flow Assay Test Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Lateral Flow Assay Test Business of Biomerieux (2020-2025)
  • Table 65. Biomerieux Recent Developments
  • Table 66. Cytiva (Danaher) Basic Information List
  • Table 67. Cytiva (Danaher) Description and Business Overview
  • Table 68. Cytiva (Danaher) Lateral Flow Assay Test Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Lateral Flow Assay Test Business of Cytiva (Danaher) (2020-2025)
  • Table 70. Cytiva (Danaher) Recent Developments
  • Table 71. Qiagen Basic Information List
  • Table 72. Qiagen Description and Business Overview
  • Table 73. Qiagen Lateral Flow Assay Test Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Lateral Flow Assay Test Business of Qiagen (2020-2025)
  • Table 75. Qiagen Recent Developments
  • Table 76. Siemens Basic Information List
  • Table 77. Siemens Description and Business Overview
  • Table 78. Siemens Lateral Flow Assay Test Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Lateral Flow Assay Test Business of Siemens (2020-2025)
  • Table 80. Siemens Recent Developments
  • Table 81. BUHLMANN Basic Information List
  • Table 82. BUHLMANN Description and Business Overview
  • Table 83. BUHLMANN Lateral Flow Assay Test Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Lateral Flow Assay Test Business of BUHLMANN (2020-2025)
  • Table 85. BUHLMANN Recent Developments
  • Table 86. IMMY Basic Information List
  • Table 87. IMMY Description and Business Overview
  • Table 88. IMMY Lateral Flow Assay Test Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Lateral Flow Assay Test Business of IMMY (2020-2025)
  • Table 90. IMMY Recent Developments
  • Table 91. Key Raw Materials Lists
  • Table 92. Raw Materials Key Suppliers Lists
  • Table 93. Lateral Flow Assay Test Downstream Customers
  • Table 94. Lateral Flow Assay Test Distributors List
  • Table 95. Research Programs/Design for This Report
  • Table 96. Key Data Information from Secondary Sources
  • Table 97. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Lateral Flow Assay Test Product Picture
  • Figure 2. Global Lateral Flow Assay Test Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Lateral Flow Assay Test Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Lateral Flow Assay Test Report Years Considered
  • Figure 5. Global Lateral Flow Assay Test Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Lateral Flow Assay Test Revenue in 2024
  • Figure 7. Lateral Flow Assay Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Sandwich Assays Picture
  • Figure 9. Competitive Assays Picture
  • Figure 10. Global Lateral Flow Assay Test Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Lateral Flow Assay Test Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Medicine
  • Figure 13. Product Picture of Environment Testing
  • Figure 14. Product Picture of Food Safety
  • Figure 15. Global Lateral Flow Assay Test Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Lateral Flow Assay Test Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Lateral Flow Assay Test Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Lateral Flow Assay Test Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Lateral Flow Assay Test Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Lateral Flow Assay Test Sales Value (%), (2020-2031)
  • Figure 28. United States Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Lateral Flow Assay Test Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Lateral Flow Assay Test Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Lateral Flow Assay Test Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Lateral Flow Assay Test Industrial Chain
  • Figure 50. Lateral Flow Assay Test Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed